Multidrug resistance associated proteins in multidrug resistance

Kamlesh Sodani1, Atish Patel, Rishil J Kathawala

  • 1Department of Pharmaceutical Sciences, St. John's University, Queens, NY 11439, USA.

Chinese Journal of Cancer
|November 22, 2011
PubMed

Insights

Multidrug resistance proteins (MRPs), a key part of ATP-binding cassette (ABC) transporters, are crucial in cancer drug resistance. This review examines the functions and roles of MRP1-MRP9 in cellular resistance and in vivo.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Multidrug resistance proteins (MRPs) are a major subfamily of ATP-binding cassette (ABC) transporters.
  • The MRP family includes 13 members, with MRP1-MRP9 primarily implicated in multidrug resistance in tumor cells.
  • These transporters extrude anticancer drugs, contributing to treatment failure.

Purpose of the Study:

  • To review the physiological functions of MRP1-MRP9.
  • To explore the cellular resistance characteristics mediated by these transporters.
  • To discuss the probable in vivo roles of MRP1-MRP9.

Main Methods:

  • Literature review of existing research on MRPs.
  • Analysis of studies focusing on MRP1-MRP9 functions.
  • Synthesis of data on transporter substrates and resistance mechanisms.

Main Results:

  • MRPs are primarily lipophilic anionic transporters, transporting glutathione (GSH), glucuronate, or sulphate conjugates.
  • MRP1-MRP3 can also transport neutral organic drugs in the presence of GSH.
  • These transporters exhibit broad substrate specificity, including anticancer drugs and physiological anions.

Conclusions:

  • MRPs play a significant role in the efflux of diverse compounds, impacting drug efficacy and physiological processes.
  • Understanding MRP functions is critical for developing strategies to overcome multidrug resistance in cancer.
  • Further research into the in vivo roles of MRP1-MRP9 is warranted.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...